Literature DB >> 18485783

Melorheostosis and FGF-23: is there a relationship?

Samar Kerkeni1, Roland Chapurlat.   

Abstract

Melorheostosis is a rare chronic bone disease of unknown etiology that often affects lower limbs. Onset usually occurs in childhood or early adolescence. The diagnosis relies on the radiographic finding of hyperostosis within or around the cortex responsible for a "flowing wax" appearance. To our knowledge, Fibroblast growth factor-23 (FGF-23) levels have not yet been quantified in melorheostosis. We report an unusual case of this disease for whom the diagnosis of fibrous dysplasia had been wrongly made for a long period of time and the FGF-23 concentration has been found very high without any disturbance of serum phosphate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485783     DOI: 10.1016/j.jbspin.2007.07.018

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  1 in total

1.  Successful treatment of pain in melorheostosis with zoledronate, with improvement on bone scintigraphy.

Authors:  Samy Slimani; Adlen Nezzar; Hachemi Makhloufi
Journal:  BMJ Case Rep       Date:  2013-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.